Trust Company of Toledo’s West Pharmaceutical WST Stock Holding History

Trust Company of Toledo’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.62K	Buy	+24	New	+$7.34K	﹤0.01%	713

Other funds holding WST

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Asset Management One

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Trust Company of Toledo's WST Position: Q2 2026 in Review

Trust Company of Toledo opened a new position in West Pharmaceutical (WST) in Q2 2026: 24 shares worth $8.62K. The stake represents ﹤0.01% of the portfolio and ranks #713 among its holdings.

287 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Trust Company of Toledo held 24 shares of West Pharmaceutical worth $8.62K as of Q2 2026.
West Pharmaceutical was a new Trust Company of Toledo position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #713 holding.
287 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.